A government-sponsored study published recently in The Open Neurology Journal concludes that cannabis provides relief to some chronic pain sufferers and that more clinical trials are needed—directly challenging DEA classification of the drug under "Schedule I," that reserved for substances with no medical uses. The study, sponsored by the State of California and conducted at the University of California Center for Medicinal Cannabis Research, calls the Schedule I placement "not accurate" and "not tenable."
Recent comments
9 weeks 3 days ago
15 weeks 1 day ago
26 weeks 1 day ago
27 weeks 23 hours ago
28 weeks 4 days ago
29 weeks 1 day ago
29 weeks 3 days ago
33 weeks 6 days ago
34 weeks 6 days ago
35 weeks 10 hours ago